Introduction edema in the CNS may contribute to development of the hemorrhages. In vitro culture of yolk sac and fetal Inversion of chromosome 16 is a consistent finding in liver cells from Cbfa2 Ϫ/Ϫ and Cbfb Ϫ/Ϫ embryos results in patients with acute myeloid leukemia subtype M4Eo (Le no myeloid or erythroid colonies. Furthermore, Cbfa2 et al., 1983) . Two chimeric genes (CBFB-MYH11 or Cbfb Ϫ/Ϫ embryonic stem (ES) cells lack myeloid and and MYH11-CBFB) are generated by this inversion, joinerythroid differentiation in culture and fail to contribute ing the CBFB gene on 16q with the MYH11 gene on 16p to hematopoiesis in chimeric mice (Okuda et al., 1996; . CBFB encodes the non-DNA-binding Wang et al., 1996a Wang et al., , 1996b ; T. S., J. D. Miller, and N. A. S., subunit (␤ subunit) of the core-binding factor (CBF, also unpublished data). These results support the hypothesis named PEBP2) (Bae et al., 1993; Ogawa et al., 1993;  that Cbfa2 and Cbfb function through the same regula- . CBF is a heterodimeric transcription tory pathway. More importantly, it is clear that their funcfactor involved in the expression regulation of genes tions are indispensable for definitive hematopoiesis and important in hematopoiesis, such as granulocyte/macthe integrity of embryonic blood circulation. rophage colony-stimulating factor (GM-CSF), interleu-
The protein encoded by the chromosome 16 inversion kin-3 (IL3), myeloperoxidase (MPO), colony-stimulating fusion gene (named CBF␤-SMMHC) retains its ability to factor-1 (CSF-1) receptor, T cell receptor ␣ (TCR␣), and bind CBF␣ and to participate in the formation of protein-TCR␤ (Cameron et al., 1994; Frank et al., 1995; Giese DNA complexes (Liu et al., 1994) . It can also form homomultimers, in contrast with the monomeric CBF␤, pre-6 These authors contributed equally to this study.
sumably through the coiled-coil domain of the myosin 7 Present address: Department of Human Genetics, Utrecht University, 3508 TA Utrecht, The Netherlands.
tail (Liu et al., 1994; Wijmenga et al., 1996) . We have also demonstrated that the CBF␤-SMMHC fusion proResults tein can interfere with the transactivation function of the normal CBF heterodimer (Liu et al., 1994) .
Generation of a Targeted Fusion between Mouse
Cbfb and a Human MYH11 cDNA Fragment To understand better the mechanism by which CBFB-MYH11 contributes to leukemogenesis, we introduced
The Cbfb targeting vector contained the murine Cbfb exon 5 fused to the 3Ј end sequence of a human CBFBthe CBFB-MYH11 gene into mouse genome and studied the effect of this fusion gene in vivo. We created the MYH11 cDNA (Liu et al., 1994 ) through a common StuI site in exon 5, located 66 bp upstream of the fusion point CBFB-MYH11 fusion oncogene in mouse ES cells by inserting the 3Ј part of the human MYH11 cDNA into ( Figure 1A ). The CBFB-MYH11 cDNA used to create the knock-in allele represents the fusion resulting from the the end of exon 5 of the mouse Cbfb gene through homologous recombination (denoted a "knock-in"). This most common type of chromosome 16 inversion (type A in Liu et al., 1995) . A polyadenylation signal sequence way, a half genomic (Cbfb), half cDNA (MYH11) fusion gene was created, which resulted in the production of from the bovine growth hormone gene was placed at the 3Ј end of MYH11. The Cbfb exon 5-MYH11 fusion a Cbf␤-SMMHC fusion protein, mimicking that found in human leukemia cells, under the control of the Cbfb sequence was flanked by sequences from introns 4 and 5 of the mouse Cbfb gene. A PGK-neo gene was inserted promoter. We demonstrate that Cbf␤-SMMHC dominantly suppresses the normal function of Cbf gene prodin intron 5 for positive selection, and the thymidine kinase gene was used for negative selection ( Figure 1B ). ucts, and blocks the differentiation of hematopoietic stem cells. Such effects of Cbf␤-SMMHC may be an
The knock-in construct was introduced into TC 1 ES cells (from mouse strain 129/SvEv; see Deng et al., 1996) important step in the leukemogenic process involving the inversion 16 fusion gene CBFB-MYH11.
by electroporation, and cell clones were selected by 40% to more than 90%, based on coat color. Southern blot hybridization of tail DNA confirmed the presence of cells derived from the targeted ES cells (Figure 2A ). The chimeric mice remained healthy 7 months after birth, with no signs of leukemia or any disturbances of hematopoietic growth and differentiation, based on their blood cell counts, hematocrits, and white blood cell differentials (data not shown). However, ES cell-derived peripheral blood cells were undetectable in these chimeras. Primers specific for the neo gene were used for polymerase chain reaction (PCR) with DNA isolated from peripheral blood of all the chimeras. None of the chimeras contained neo-positive peripheral blood cells ( Figure  2B ). This result was confirmed by glucose-6-phosphate isomerase (GPI) isozyme assay. Cells in chimeric mice originating from the injected TC 1 ES cells (129/Sv) should contain the I a isoform of GPI, whereas cells derived from the C57BL/6 blastocysts should contain the I b isoform of GPI. As shown in Figure 2C , kidney, skeletal muscle, and heart from all four chimeric mice studied contained both the GPI-I a and GPI-I b isoforms (the intensity of the GPI-I a band in the heart lanes was variable among the four chimeras), indicating that ES cells contributed significantly to these non-hematopoietic tissues. On the other hand, peripheral blood, bone marrow, and thymus contained exclusively the I b isoform of and ES 94) had successful germline transmission, as indicated by the high percentage of pups with agouti coat color. However, none of these liveborn agouti pups growth in media containing G418/FIAU. Drug-resistant inherited the Cbfb-MYH11 fusion gene (Table 1) . ES clones were screened by Southern blot hybridization When embryos at different developmental stages for homologous recombination of the Cbfb-MYH11 fuwere examined, it was discovered that Cbfb-MYH11 sion sequence into one of the endogenous Cbfb alleles.
heterozygous embryos died in utero between embryonic We identified 5 of 120 Neo/FIAU-resistant ES clones to days 11.5 (E11.5) and 13.5 (E13.5; Table 1 ). At E11.5, all have the correct insertion ( Figure 1C ), and two clones embryos appeared normal; ‫%05ف‬ were heterozygous (ES 55 and ES 94) were used for further studies.
for Cbfb-MYH11, as detected by PCR with yolk sac DNA. Embryos heterozygous for the Cbfb-MYH11 allele looked identical to wild-type embryos in size and devel-ES Cells Heterozygous for the Cbfb-MYH11 Allele Do Not Contribute to Hematopoietic opmental stage, and no abnormalities were observed histologically (data not shown). Starting at E12.0, CbfbTissues in Chimeric Mice Two independently targeted ES cell clones were injected MYH11 heterozygous embryos developed multiple hemorrhages, most frequently in the CNS. By E12.5, all the into C57BL/6 blastocysts, and chimeric mice were generated with varying degrees of chimerism, ranging from
Cbfb-MYH11 heterozygous embryos had hemorrhages ( Figure 3A ) except one (Table 1 ), but about half of them the ganglia of the VII and VIII cranial nerves (Figures 3A and 3C) and dorsal root ganglia, as well as in regions were still alive, based on continued heart beats ( Table  1) . By E13.5, all the Cbfb-MYH11 heterozygous embryos adjacent to somites ( Figure 3A ). Several embryos had massive hemorrhages in the pericardial and peritoneal were dead, presumably from massive hemorrhages. There were no developmental defects nor delays in decavities, the origin of which has not been clearly defined ( Figure 3D ). We also noted multifocal cellular degeneravelopment up to this time.
Hemorrhages were found most frequently in the perition or apoptosis in the areas prone to hemorrhage ( Figure 3E ), as reported for Cbfa2 and Cbfb knock-out ventricular regions of the striatum, pons, medulla, and spinal cord ( Figures 3A and 3B) . Extravascular blood embryos (Wang et al., 1996a (Wang et al., , 1996b . Therefore, hemorrhages in Cbfb-MYH11 heterozygous embryos apoften extended through the ependyma, leading to the accumulation of large amounts of blood in the ventricles peared to be associated with areas of apoptosis, as has been described for Cbfa2 and Cbfb knock-out embryos of the developing brain and the spinal cord ( Figure 3A) . Intraparenchymal hemorrhages were also frequent at (Wang et al., 1996a (Wang et al., , 1996b . targeted insertion of the MYH11 cDNA resulted in the creation of a Cbfb-MYH11 fusion gene and the production of a fusion transcript and a fusion protein identical to those found in leukemic cells with a chromosome 16 inversion.
Lack of Fetal Liver Hematopoiesis
The livers of the E11.5-13.5 Cbfb-MYH11 heterozygous embryos were very pale and small in size, compared with livers from wild-type embryos of the same gestational ages (see Figure 3A) . Histologically, livers of the Cbfb-MYH11 heterozygous embryos contained very few, if any, erythropoietic cells, and no identifiable megakaryocytes (see Figure 3F ). Only circulating, yolk sacderived primitive erythrocytes were observed in liver sinusoids, while hepatic cords were devoid of definitive hematopoietic cells. This was in sharp contrast with the wild-type embryo livers, in which numerous hematopoietic cells at different developmental stages were present throughout the hepatic cords (see Figure 3G ). Noticeably, megakaryocytes were evident in the wild-type liver; at least one can be seen in every field at high magnifica- 
Hematopoiesis In Vitro
We also performed in vitro colony-forming assays to Expression of Cbfb-MYH11 Fusion Gene assess the capacity of definitive hematopoiesis with feProducts from the Knocked-In Allele tal liver, yolk sac, and ES cells. For wild-type embryos, The expression of the targeted allele in the embryos was E11.5-E12.5 fetal liver cells and E10.5 yolk sac cells examined by reverse transcriptase-polymerase chain proliferated and differentiated in methylcellulose culreaction (RT-PCR) and Western blot analysis using RNA tures under conditions that support definitive hematoand proteins isolated from embryos. RT-PCR was conpoiesis, and many hematopoietic colonies were formed ducted with a primer at the junction of exons 3 and 4 (Table 2 ). In comparison, fetal liver and yolk sac cells of Cbfb and another primer from the MYH11 cDNA, using isolated from Cbfb-MYH11 heterozygous littermates RNA samples from E12.5 wild-type embryos and emhad a highly reduced capacity to proliferate and differenbryos heterozygous for the knocked-in gene. A cDNA tiate in vitro, as the number of colonies of myeloid linfragment of the expected size (415 bp) for the Cbfbeage in the culture was about 0%-1% of the wild type MYH11 fusion transcript was observed only with RNA (Table 2) . Initially, we observed very few erythroid cellof embryos heterozygous for Cbfb-MYH11 ( Figure 4A ).
containing colonies (CFU-E) from yolk sac and fetal liver By Western blotting, proteins of the expected size (71 cells of wild-type embryos. The numbers of erythroid kD) for the Cbf␤-SMMHC fusion protein were detected cell-containing colonies of wild-type embryos differed in E12.5 embryos heterozygous for the knocked-in significantly from those of the Cbfb-MYH11 heterozyCbfb-MYH11 gene ( Figure 4B ), using a monoclonal antigous embryos by statistical analysis (Table 2) , but the body (␤141.2) specific for Cbf␤ (Wang et al., 1996b) . differences were far less than those for the myeloid The Cbf␤-SMMHC fusion protein migrated as a doublet, colonies. We learned later that there is not enough erythwhich could reflect post-translational modifications of ropoietin in the media (MethoCult M3430, StemCell a portion of the fusion proteins. In addition, the wildTechnologies, Inc.) to support growth of erythroid cells. type Cbf␤ protein was detected in both wild-type and When additional erythropoietin was added to the culCbfb-MYH11 heterozygous embryos. Western blot detures, many erythroid lineage colonies were produced tection using serial dilutions of the proteins indicated from wild-type fetal liver and none from the Cbfb-MYH11 that Cbf␤-SMMHC protein was present in these emheterozygous fetal liver (E12.0 Liver, Table 2 ). Therefore, bryos at a relatively lower level (<2-fold difference) than the failure of definitive hematopoiesis in the Cbfbthe wild-type Cbf␤ (presuming equal transfer of both MYH11 heterozygous embryos is panblastic. Moreover, proteins and equal affinity of the antibody to both pro-ES cells of two independent knock-in clones used for teins) (data not shown). Taken together, the results of blastocyst injection had a similar defect in their ability to form secondary hematopoietic colonies compared RT-PCR and Western blot analyses confirmed that the with the original TC 1 ES cells (data not shown). These to the Cbfb-MYH11 fusion gene is sufficient to block definitive hematopoiesis, equivalent to the effect of hoin vitro colony-forming assays provided supporting evidence that converting one allele of the murine Cbfb gene mozygous deletions of Cbfb and Cbfa2. 
Impairment of Maturation of Yolk
resulting from the Cbfb-MYH11 knock-in allele is strikSac-Derived Erythroblasts ingly similar to that associated with homozygous disrupIn peripheral blood, we noticed a large number of circution of the Cbfa2 and Cbfb genes. Although it was prelating erythroblasts in the Cbfb-MYH11 heterozygous sumed that the CBFB-MYH11 fusion gene is dominant, embryos at E12.5 ( Figure 5A ). The vast majority of the since only one of the two sets of CBFB and MYH11 circulating blood cells from wild-type ( Figure 5B ) and genes is disrupted by the chromosome 16 inversion in Cbfb Ϫ/Ϫ embryos (data not shown, see Figure 4A in Wang leukemic cells, our results unequivocally demonstrate et al., 1996b) were the mature nucleated erythrocytes (or that CBFB-MYH11 behaves in a dominant fashion. The metarubricytes), derived from the yolk sac. Enucleated similarity of the phenotypes associated with Cbfa2 Ϫ/Ϫ , erythrocytes, derived from definitive erythropoiesis in Cbfb
, and Cbfb-MYH11 mutations strongly suggests the fetal liver, were also frequent in the peripheral blood that the Cbf␤-SMMHC protein acts in a dominant negaof the wild-type embryos, but were rare in the blood of tive manner to block wild-type Cbf function. Cbfb Ϫ/Ϫ embryos. Occasionally, immature erythroblasts, Although the striking similarity of the phenotypes asalso called rubriblasts, prorubricytes, and rubricytes, sociated with heterozygosity of the Cbfb-MYH11 fusion could be seen in the blood of these two types of emgene and homozygous disruption of either Cbfa2 or Cbfb bryos. In contrast, the peripheral blood of the Cbfbsuggests a dominant negative role for Cbfb-MYH11, at MYH11 heterozygous embryos contained many immaleast during embryonic development, exactly how the ture erythroblasts ( Figure 5A ). As shown in Figure 5G , Cbfb-MYH11 gene product negatively affects Cbfb and more than 78% of circulating cells in the E12.5 CbfbCbfa2 function is unclear. We previously showed that MYH11 heterozygous embryos were immature erythro-CBF␤-SMMHC can form high molecular weight multiblasts, whereas 80% of the cells in Cbfb Ϫ/Ϫ embryos mers (Liu et al., 1994; Wijmenga et al., 1996) . One possiand 87% in wild-type embryos were mature nucleated ble mechanism by which Cbf␤-SMMHC transdomiprimitive erythrocytes.
nantly interferes with CBF function might be through the The circulating immature erythroblasts in the E12.5 assembly of Cbf␤-SMMHC multimers that trap Cbf␣ in embryos heterozygous for Cbfb-MYH11 were most non-functional complexes, thus reducing the effective likely derived from the yolk sac, and reflected a delay Cbf␣ concentration in cells. Wang et al. (1996b) suggest or partial blockage of maturation of the primitive erythrothat Cbf␣2 is limiting in hematopoietic progenitor cells blasts. At E10.0, the circulating blood of both Cbfbor pluripotent stem cells; thus, modest decreases in the MYH11 heterozygous and wild-type embryos consisted cellular Cbf␣2 concentration could be sufficient to block almost exclusively of rubriblasts ( Figures 5C and 5D) , hematopoiesis (Wang et al., 1996b) . Another possible which were released into circulation from the yolk sac mechanism for transdominant interference is that Cbf␤-to continue proliferation and maturation. There were no SMMHC:Cbf␣2 multimers might assemble on CBF tarsignificant differences between the wild-type and the get sequences and block transcription. This could inCbfb-MYH11 heterozygous embryos at this stage, indivolve direct inhibition of transcription mediated by cating that the initiation of primitive hematopoiesis was interaction of Cbf␤-SMMHC with general transcription apparently normal in embryos heterozygous for Cbfbfactors assembled at the promoter. Alternatively, CBF MYH11. This was supported by histological examinacomplexes containing Cbf␤-SMMHC multimers could tions of yolk sacs from the Cbfb-MYH11 heterozygous interfere with binding of other transcription factors to embryos, which revealed no abnormalities (data not adjacent sites on promoters or enhancers of CBF target shown). At E11.5, embryonic blood from both wild-type genes. The CBF␤-SMMHC fusion protein is considerand Cbfb-MYH11 heterozygous embryos contained a ably larger than the wild-type CBF␤ protein (71 kD versus spectrum of rubriblasts, prorubricytes, and rubricytes, 22 kD), and could conceivably occupy a much larger reflecting the ongoing maturation process (Figures 5E region on DNA, especially in its multimeric form. Since and 5F). Further maturation of primitive erythrocytes CBF has been shown to cooperate with transcription between E11.5 and E12.5 was significantly impaired in factors such as ets-1, c-Myb, and CCAAT enhancerthe embryos heterozygous for Cbfb-MYH11, resulting binding protein (C/EBP) to activate transcription (Giese in the accumulation of a large number of immature erythet al., 1995; Hernandez-Munain and Krangel, 1994, 1995 ; roblasts in the circulation. This defect was not detected Sun et al., 1995; Wotton et al., 1994; Zaiman et al., 1995 ; in the embryos with homozygous deletions of Cbfa2 and Zhang et al., 1996) , Cbf␤-SMMHC complexes might inCbfb genes; therefore, it suggests a gain of function of terfere with the recruitment of essential CBF partner the Cbfb-MYH11 fusion gene.
proteins to the promoter. The end result of the latter mechanism of transdominant interference could be conDiscussion text dependent. This is consistent with the observation that transcription from some enhancers (e.g., MMLV) The CBFA2 and CBFB genes encode subunits of the was suppressed, while transcription from other enheterodimeric CBF complex. Both genes are required hancers (RSV) was moderately stimulated by the CBFBfor fetal liver hematopoiesis and are disrupted in a large MYH11 gene in transient transfection assays (Liu et al. , percentage of human leukemias by chromosomal trans-1994; P. P. L., unpublished data). locations. Here, we show that mice heterozygous for a A defect in primitive hematopoiesis was also observed Cbfb-MYH11 knock-in allele, which mimics the allele in Cbfb-MYH11 heterozygous embryos that was not apgenerated by inversion of chromosome 16 associated parent in Cbfb Ϫ/Ϫ and Cbfa2 Ϫ/Ϫ embryos, suggesting that with acute myeloid leukemia subtype M4Eo, die in midtransdominant interference by the Cbf␤-SMMHC fusion gestation from extensive hemorrhages and have severely impaired fetal liver hematopoiesis. The phenotype protein involves more than simple loss of Cbf␣2 or Cbf␤ function. It is not clear whether the Cbfb-MYH11 allele to the development of hematopoietic malignancies, probably requiring a second mutation, cannot be addisrupts an entirely new pathway (primitive erythropoiesis) not normally regulated by CBF, or whether in fact dressed in this system, since the embryos die prematurely as a consequence of a separate defect. The aba minor impairment of yolk sac hematopoiesis also occurred in Cbfa2-and Cbfb-deficient embryos that was sence of leukemia in Cbfb-MYH11 chimeric mice may suggest that a second step is required. Future experitoo subtle to detect by histological methods. In either case, the interference mechanism discussed above mental designs that result in the rescue of the embryonic lethality of the Cbfb-MYH11 gene or the generation of could explain why primitive erythropoiesis does not require CBF but can be disrupted by a transdominant the Cbfb-MYH11 fusion gene or gene product only after birth should lead to the test of the full leukemogenic negative derivative of CBF. We hypothesize that certain genes required for primitive hematopoiesis contain potential of this important leukemia-specific fusion gene. binding sites for CBF but that normal CBF is not absolutely required for transcription from these genes, and may in fact contribute very little to their expression. If Experimental Procedures this were the case, then loss of CBF function would
ES Cell Targeting
have little or no effect on primitive erythropoiesis. On
The targeting construct was assembled in the plasmid vector pPNT, the other hand, a Cbf␤-SMMHC protein bound to these which included a thymidine kinase gene expressed from a PGK same sites in genes required for primitive erythropoiesis promoter (PGK-tk) for positive selection (Deng et al., 1996) . A 3.5 might actively interfere with the assembly of other nec- Robb et al., 1995; Shivdasani et al., 1995; thus preventing the expression of the leukemogenic potential of Cbfb-MYH11 in adult mice. However, the Cbfb-MYH11 knock-in model presented here does provide
Genotype Analysis
The presence of the Cbfb-MYH11 allele in mice was assessed by very powerful evidence for a dominant negative function Southern blot hybridization and/or PCR from DNA isolated from tail of Cbfb-MYH11 in the CBF pathway, and demonstrates snips, yolk sacs, or whole embryos. For the Southern blot analysis, the importance of this fusion gene in the regulation of 10 g of genomic DNA was digested with NcoI and analyzed using growth and differentiation of hematopoietic cells. standard procedures. Hybridized blots were exposed to phosphor
The pathogenesis of leukemia is probably a multistep screens (Molecular Dynamics, Sunnyvale, CA), and developed and process, just as is that for solid tumors. The end result analyzed using PhosphorImager imaging systems (Molecular Dynamics). We amplified 50 ng of template DNA by PCR using neois the blockage of differentiation and uncontrolled prolifspecific primers (neo forward 5Ј-AGAGGCTATTCGGCTATGA eration of immature blast cells of various lineages. The CTG-3Ј, and neo reverse 5Ј-TTCGTCCAGATCATCCTGATC-3Ј). The results presented here provide evidence that the fusion PCR samples were initially denatured at 94ЊC for 2 min, followed gene CBFB-MYH11, created by chromosome 16 inverby 30 cycles of amplification (30 s each at 94ЊC, 60ЊC, and 72ЊC), sion in acute myeloid leukemia subtype M4Eo, is capaand a final 5 min extension step at 72ЊC. The quality of template ble of blocking hematopoietic differentiation, an impor-DNA was confirmed in a parallel amplification with primers specific for sequences from the Trp53 gene (P6.6F 5Ј-ACAGCGTGGTGG tant step in leukemogenesis. Whether this step will lead TACCTTATG-3Ј, and P7.1R 5Ј-GGTATACTCAGAGCCGGCCT-3Ј), 5 ml of ␣-MEM/5% FBS/3% BSA at 4ЊC, and disrupted into singlecell suspensions by passing through needles. Three cell dilutions using the same PCR conditions as described above.
(2 ϫ 10 3 , 1 ϫ 10 4 , and 5 ϫ 10 4 ) were plated in the same methylcellulose mix and conditions as described above for yolk sacs cultures Cbfb-MYH11 RNA Analysis (except for liver cells of E12.0 embryos, for which additional erythroTotal RNA was isolated from ES cells and whole embryos using the poietin was added at 2 U/ml), and colonies were scored at day 7. RNA STAT-60 kit (TEL-TEST, Inc., Friendswood, TX) and reverse-
The scoring of colony-forming unit-erythroid (CFU-E), colonytranscribed with oligo-dT primers (Invitrogen, San Diego, CA) and forming unit-granulocyte/macrophage (CFU-GM), and colony-formSuperscript II RT reverse transcriptase (GIBCO-BRL, Gaithersburg, ing unit-granulocyte/erythroid/macrophage/megakaryocyte (CFU-MD) using standard methods, and 1 g of the RT product was used GEMM) colonies were performed following Eaves and Lambie as template in each amplification reaction. The presence of the (1995) . Cbfb-MYH11 cDNA was identified using a sense primer that spans
In vitro differentiation experiments of ES cells were performed the exon 3-4 boundary of the mouse Cbfb gene (mC3/4.1F: following the procedures as described in Wang et al. (1996a) . 5Ј-GCAGGCAAGGTATACTTGAAGG-3Ј) and an antisense primer included in the human MYH11 cDNA (MHC3ЈA: 5Ј-CTCTTCTCCTCATT CTGCTC-3Ј). The quality of the reverse-transcribed cDNA was con
